Bacterial reprogramming of PBMCs impairs monocyte phagocytosis and modulates adaptive T cell responses

Journal of Leukocyte Biology

Volumn 91, Issue 6, 2012, Pages 977-989

  André, Maya C ^a   Gille, Christian ^a   Glemser, Philip ^a   Woiterski, Jeanette ^a   Hsu, Hsin Yun ^c,d   Spring, Baerbel ^a   Keppeler, Hildegard ^c   Kramer, Boris W ^e   Handgretinger, Rupert ^a   Poets, Christian F ^a   Lauber, Kirsten ^c,f   Orlikowsky, Thorsten W ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti inflammatory response; E. coli; TH17; TLR

Indexed keywords

CD16 ANTIGEN; CD36 ANTIGEN; CD64 ANTIGEN; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ARTICLE; CELL ACTIVITY; CELL PHAGOCYTOSIS; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; NUCLEAR REPROGRAMMING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY INFECTION; T LYMPHOCYTE; TH17 CELL;

ADAPTIVE IMMUNITY; ADULT; BIOLOGICAL MARKERS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MONOCYTES; PHAGOCYTOSIS; RECEPTORS, IGG; SEPSIS; TH17 CELLS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84861976350     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0911474     Document Type: Article

References (36)

1. Docke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D., Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3, 678-681.
2. Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C., Volk, H. D. (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J. Exp. Med. 181, 1887-1892.
3. Wolk, K., Döcke, W. D., von Baehr, V., Volk, H. D., Sabat, R. (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96, 218-223.
4. Kramer, B. W., Ikegami, M., Moss, T. J., Nitsos, I., Newnham, J. P., Jobe, A. H. (2005) Endotoxin-induced chorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am. J. Respir. Crit. Care Med. 171, 73-77.
5. Monneret, G., Finck, M. E., Venet, F., Debard, A. L., Bohe, J., Bienvenu, J., Lepape, A. (2004) The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol. Lett. 95, 193-198.
6. Schroder, M., Meisel, C., Buhl, K., Profanter, N., Sievert, N., Volk, H. D., Grutz, G. (2003) Different modes of IL-10 and TGF-β to inhibit cytokine-dependent IFN-γ production: consequences for reversal of lipopolysaccharide desensitization. J. Immunol. 170, 5260-5267.
7. Del Fresno, C., Garcia-Rio, F., Gomez-Pina, V., Soares-Schanoski, A., Fernandez-Ruiz, I., Jurado, T., Kajiji, T., Shu, C., Marin, E., Gutierrez, del Arroyo, A., Prados, C., Arnalich, F., Fuentes-Prior, P., Biswas, S. K., Lopez-Collazo, E. (2009) Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 182, 6494-6507.
8. Munoz, C., Carlet, J., Fitting, C., Misset, B., Bleriot, J. P., Cavaillon, J. M. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88, 1747-1754.
9. Gille, C., Leiber, A., Mundle, I., Spring, B., Abele, H., Spellerberg, B., Hartmann, H., Poets, C. F., Orlikowsky, T. W. (2009) Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein-labeled Escherichia coli and group B Streptococci. Cytometry B Clin. Cytom. 76, 271-284.
10. Gille, C., Spring, B., Tewes, L., Poets, C. F., Orlikowsky, T. (2006) A new method to quantify phagocytosis and intracellular degradation using green fluorescent protein-labeled Escherichia coli: comparison of cord blood macrophages and peripheral blood macrophages of healthy adults. Cytometry A 69, 152-154.
11. Dehio, M., Knorre, A., Lanz, C., Dehio, C. (1998) Construction of versatile high-level expression vectors for Bartonella henselae and the use of green fluorescent protein as a new expression marker. Gene 215, 223-229.
12. Sierra-Filardi, E., Puig-Kröger, A., Blanco, F. J., Nieto, C., Bragado, R., Palomero, M. I., Bernabéu, C., Vega, M. A., Corbí, A. L. (2011) Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117, 5092-5101.
13. Hsu, H. Y., Wittemann, S., Joos, T. O. (2008) Miniaturized parallelized sandwich immunoassays. Methods Mol. Biol. 428, 247-261.
14. Hsu, H. Y., Wittemann, S., Schneider, E. M., Weiss, M., Joos, T. O. (2008) Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases. Med. Eng. Phys. 30, 976-983.
15. Peter, C., Waibel, M., Radu, C. G., Yang, L. V., Witte, O. N., Schulze-Osthoff, K., Wesselborg, S., Lauber, K. (2008) Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A. J. Biol. Chem. 283, 5296-5305.
16. Gille, C., Leiber, A., Spring, B., Kempf, V. A., Loeffler, J., Poets, C. F., Orlikowsky, T. W. (2008) Diminished phagocytosis-induced cell death (PICD) in neonatal monocytes upon infection with Escherichia coli. Pediatr. Res. 63, 33-38.
17. Hotchkiss, R. S., Swanson, P. E., Cobb, J. P., Jacobson, A., Buchman, T. G., Karl, I. E. (1997) Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T-and B-cell-deficient mice. Crit. Care Med. 25, 1298-1307.
18. Park, S. H., Park-Min, K. H., Chen, J., Hu, X., Ivashkiv, L. B. (2011) Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 12, 607-615.
19. Hotchkiss, R. S., Karl, I. E. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138-150.
20. Osuchowski, M. F., Welch, K., Siddiqui, J., Remick, D. G. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974.
21. Kox, W. J., Volk, T., Kox, S. N., Volk, H. D. (2000) Immunomodulatory therapies in sepsis. Intensive Care Med. 26 (Suppl. 1), S124-S128.
22. Van der Sluijs, K. F., Nijhuis, M., Levels, J. H., Florquin, S., Mellor, A. L., Jansen, H. M., van der Poll, T., Lutter, R. (2006) Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J. Infect. Dis. 193, 214-222.
23. Van der Sluijs, K. F., van Elden, L. J., Nijhuis, M., Schuurman, R., Pater, J. M., Florquin, S., Goldman, M., Jansen, H. M., Lutter, R., van der Poll, T. (2004) IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol. 172, 7603-7609.
24. Cavaillon, J. M., Pitton, C., Fitting, C. (1994) Endotoxin tolerance is not a LPS-specific phenomenon: partial momicry with IL-1, IL-10 and TGF-β. J. Endotoxin Res. 1, 21-29.
25. Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H. D., Docke, W. D. (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101, 783-794.
26. Wyant, T. L., Tanner, M. K., Sztein, M. B. (1999) Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect. Immun. 67, 1338-1346.
27. Boldrick, J. C., Alizadeh, A. A., Diehn, M., Dudoit, S., Liu, C. L., Belcher, C. E., Botstein, D., Staudt, L. M., Brown, P. O., Relman, D. A. (2002) Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. USA 99, 972-977.
28. Nau, G. J., Richmond, J. F., Schlesinger, A., Jennings, E. G., Lander, E. S., Young, R. A. (2002) Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99, 1503-1508.
29. Pfeiffer, A., Bottcher, A., Orso, E., Kapinsky, M., Nagy, P., Bodnar, A., Spreitzer, I., Liebisch, G., Drobnik, W., Gempel, K., Horn, M., Holmer, S., Hartung, T., Multhoff, G., Schutz, G., Schindler, H., Ulmer, A. J., Heine, H., Stelter, F., Schutt, C., Rothe, G., Szollosi, J., Damjanovich, S., Schmitz, G. (2001) Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31, 3153-3164.
30. Sun, K., Metzger, D. W. (2008) Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nat. Med. 14, 558-564.
31. Torchinsky, M. B., Garaude, J., Martin, A. P., Blander, J. M. (2009) Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458, 78-82.
32. Evans, H. G., Suddason, T., Jackson, I., Taams, L. S., Lord, G. M. (2007) Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104, 17034-17039.
33. Kolls, J. K., Linden, A. (2004) Interleukin-17 family members and inflammation. Immunity 21, 467-476.
34. Ouyang, W., Kolls, J. K., Zheng, Y. (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467.
35. Shibata, K., Yamada, H., Hara, H., Kishihara, K., Yoshikai, Y. (2007) Resident Vδ1+ γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466-4472.
36. Neely, C. J., Maile, R., Wang, M. J., Vadlamudi, S., Meyer, A. A., Cairns, B. A. 2011. Th17 (IFNγ-IL-17+) CD4+ T cells generated after burn injury may be a novel cellular mechanism for postburn injuries. J. Trauma 70, 681-690.